Let's work to conquer cancer. Together.
Accelerate your cancer research
The QIAGEN Cancer Research Community is for dedicated and passionate cancer researchers. We are working to conquer cancer with an emphasis on collaborating together worldwide to share knowledge, methods and data to enable breakthroughs in cancer research.
Digital PCR for monitoring MRD in AMLJoin us for the November Cancer Research Lecture by Dr. Amanda Winters on the role of digital PCR in monitoring MRD and guiding tailored therapy in AML patients.
EV biomarker webinar on-demandThe path from exosomes and EV biomarker research to real-world application is not always easy. That’s why we’ve asked four experts to share their insights with us. Watch our webinar on-demand to learn more.
Cell-free DNA from liquid biopsies
From biomarker research to personalized medicine, cell-free DNA isolated from liquid biopsies provides a powerful method to monitor cancer development in future. Enjoy three talks by cancer researchers and “Ask-Me-Anything” sessions with R&D experts.
Multianalyte Liquid BiopsiesWorking with cell-free DNA, extracellular vesicles or CTCs? How would the picture change if all analytes could be investigated from the same sample?
Elaine Mardis, Columbus, Ohio, USA“I’m constantly inspired by cancer patients, especially our pediatric patients, and their families.”
Klaus Pantel, Hamburg, Germany“Each year almost 10 million people die of cancer worldwide and to contribute translational cancer research with the potential to reduce this number is my strongest motivation.”
Pithi Chanvorachote, Bangkok, Thailand“Understanding the defined molecular network and signaling of cancers can lead to discovering the ultimate drug targets that can then result in the best treatment.”
Sabine Kasimir-Bauer, Essen, Germany“I have built a wonderful scientific network and made friends with people from all over the world.”
Seock-Ah Im, Seoul, Republic of Korea“We must build a more comprehensive network to facilitate academia, global pharmaceutical company and the biotechnology industry to run together.”
Sue Branford, Adelaide, Australia“We continue to work toward finding the reasons why some patients don’t have a successful outcome.”
Toh Han Chong, Singapore“Learn from setbacks, come back stronger, love the journey of discovery and creating new knowledge, and always have a dream, vision and hope.”
You?What inspires you to do cancer research? We are happy to give these insights into the lives and work of cancer researchers. If you would like to share your story here, get in touch.
QIAGEN Cancer Research Lecture Series
Consortia and initiatives – we're working together
QIAGEN participates in numerous renowned international consortia, grant projects and initiatives that strive to improve global healthcare. They extend and access networks and infrastructures – and stimulate exchange between all relevant stakeholders – from science, medicine and government. Our active role in consortia and initiatives keeps QIAGEN at the forefront of scientific findings and developments.
- European Liquid Biopsy Society (ELBS)
- Cancer ID – a new way to track cancer
- SPIDIA4P – better diagnosis and medical research
- CBmed – biomarker identification, validation and research
- EASI-Genomics – cutting-edge DNA sequencing technologies
- EU-STANDS4PM – standards for in silico approaches in personalized medicine